World Sickle Cell Day | WIBC

Innovative Hematology, home to the Indiana Hemophilia & Thrombosis Center (IHTC), announces the launch of its Gene Therapy Hub—Indiana’s only comprehensive center providing on-site gene therapy for hemophilia.

While the core principles of venous thromboembolism (VTE) management apply broadly, tailoring care to the female patient can improve outcomes and reduce complications.

The Innovative Hematology Board of Directors appointed Sanjay P. Ahuja, MD, MSc, MBA as Chief Executive Officer & Medical Director of Innovative Hematology, effective April 1, 2026